Business Standard

Alembic Pharmaceuticals net profit rises 53.92% in the September 2013 quarter

Image

Capital Market

Sales rise 19.47% to Rs 484.80 crore

Net profit of Alembic Pharmaceuticals rose 53.92% to Rs 63.83 crore in the quarter ended September 2013 as against Rs 41.47 crore during the previous quarter ended September 2012. Sales rose 19.47% to Rs 484.80 crore in the quarter ended September 2013 as against Rs 405.80 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales484.80405.80 19 OPM %19.5815.66 -PBDT92.5360.65 53 PBT82.6851.83 60 NP63.8341.47 54

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 26 2013 | 8:46 AM IST

Explore News